We are live on !
Find out more
OL
Odyssean LLC Portfolio holdings
AUM
$866M
Turnover
38.09%
1-Year Est. Return
42.65%
This Fund
S&P 500
This Quarter Est. Return
+3.71%
1 Year Est. Return
+42.65%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$866M
AUM Growth
+$251M
(+41%)
Cap. Flow
+$260M
Cap. Flow % of AUM
Cap. Flow %
30.08%
Top 10 Holdings %
Top 10 Hldgs %
5.29%
Holding
575
New
90
Increased
217
Reduced
38
Closed
129
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$4.7M |
| 2 |
PPL
PPL
|
+$4.68M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$4.39M |
| 4 |
ZoomInfo Technologies
GTM
|
+$4.34M |
| 5 |
Pebblebrook Hotel Trust
PEB
|
+$4.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ultragenyx Pharmaceutical
RARE
|
+$4.08M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$3.16M |
| 3 |
Yelp
YELP
|
+$3.16M |
| 4 |
American Electric Power
AEP
|
+$3.15M |
| 5 |
Southern Company
SO
|
+$3.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.33% |
| 2 | Healthcare | 16.37% |
| 3 | Financials | 15.49% |
| 4 | Industrials | 8.24% |
| 5 | Real Estate | 7.11% |
Similar funds
HCP
KAS
Odyssean LLC's Q3 2026 Portfolio in Review
As of Q3 2026, Odyssean LLC held 575 positions worth $866M, up 41% from $615M the previous quarter. Its ten largest holdings account for 5.3% of the portfolio.
Odyssean LLC deployed $260M of net new capital in Q3 2026, opening 90 new positions and adding to 217 existing holdings. Its largest new stake was BILL Holdings: 101,841 shares worth $4.33M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Mirum Pharmaceuticals, an estimated $1.83M trimmed.
- Odyssean LLC's largest Q3 2026 buy was BILL Holdings: 101,841 shares worth $4.33M.
- Odyssean LLC added most to Broadstone Net Lease in Q3 2026, an estimated $4.24M increase.
- Odyssean LLC's biggest Q3 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $1.83M.
- Odyssean LLC fully exited Ultragenyx Pharmaceutical in Q3 2026, selling an estimated $4.08M.
- Odyssean LLC's ten largest holdings make up 5.3% of its $866M portfolio in Q3 2026.
- Odyssean LLC opened 90 new positions and closed 129 in Q3 2026.
- Odyssean LLC's portfolio value rose 41% quarter-over-quarter to $866M.
Based on Odyssean LLC's 13F filing for Q3 2026, filed 16 Nov 2026.